Stay updated on PF-06439535 vs Bevacizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site release rather than any change to the underlying clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-26T15:27:19.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added Valparaiso and Araucania locations, including Temuco, Araucania, Chile (4810469) and Viña del Mar, Valparaiso, Chile (2540364). Removed Temuco, Región de la Araucanía, Chile (4810469) and Viña del Mar, Región de Valparaíso, Chile (2540364); revision updated from v3.5.0 to v3.5.2.
    Difference
    0.2%
    Check dated 2026-04-19T13:43:29.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T20:05:52.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and the previous v3.4.2 revision was removed.
    Difference
    0.0%
    Check dated 2026-03-07T13:13:09.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and Revision: v3.4.1 was removed, a minor site version update that does not affect study content or user actions; to avoid alerts for small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T17:07:52.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Revision metadata updated: Revision: v3.4.1 was added and Revision: v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T11:26:48.000Z thumbnail image

Stay in the know with updates to PF-06439535 vs Bevacizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.